Found: 6
Select item for more details and to access through your institution.
Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion.
- Published in:
- Oncogene, 2013, v. 32, n. 9, p. 1110, doi. 10.1038/onc.2012.139
- By:
- Publication type:
- Article
Trajectories and risk factors of fatigue following colorectal cancer diagnosis.
- Published in:
- Colorectal Disease, 2023, v. 25, n. 10, p. 2054, doi. 10.1111/codi.16746
- By:
- Publication type:
- Article
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 10, p. 2112, doi. 10.1038/leu.2013.229
- By:
- Publication type:
- Article
Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 4, p. 897, doi. 10.1038/leu.2012.300
- By:
- Publication type:
- Article
Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literature.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1388, doi. 10.1038/bmt.2015.168
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 296, doi. 10.1038/bmt.2014.233
- By:
- Publication type:
- Article